CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) INTEGRATED CARE PATHWAY PROJECT: EVALUATION OF PATIENT OUTCOMES AND SYSTEM EFFICIENCIES

Main Article Content

Ola S Norrie
Rose Dziadekwich
Raquel Fernandes
Colleen J Metge

Keywords

Chronic Obstructive Pulmonary Disease

Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic progressive respiratory disease with partially reversible airway obstruction and lung hyperventilation progressing to increasingly frequent and severe exacerbations. The condition is mainly caused by smoking but may result from other causes such as environmental exposure or occupational hazards. Based on Statistics Canada survey data the prevalence of COPD is approximately 4% of the general population, or about 780,000 adults in Canada with 28,000 in Manitoba.

Abstract 200 | PDF Downloads 209

References

1. Statistics Canada. Chronic obstructive pulmonary disease (COPD) in the household population aged 35 to 79, by age and sex, Canada 2009-2011, Table 32. Ottawa: Author; 2011.
2. O’Donnel DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J 2008;(15 Suppl A):1A-8A. PMID: 18292855, PMCID: PMC2802325.
3. O’Shea Y. Improving the patient journey: Understanding integrate care pathways; foreword. Dublin: National Council for the Professional Development of Nursing and Midwifery; 2006.
4. Davis N. Integrated care pathways: A guide to good practice. Wales: National Leadership and Innovation Agency for Healthcare; 2005.
5. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 1999;89:1322-7. PMID: 10474547.
6. CONSORT. CONSORT 2010 Flow Diagram. CONSORT transparent reporting of trials. [Online]; 2010. Available at: www.consort-statement.org/ consort-statement/flow-diagram.
7. Stenton C The MRC breathlessness scale Occup Med (Lond) 2008;58:226-7. PMID: 18441368.
8. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;(20):1727- 36.
9. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-54.
10. Washburn RA, Smith KW, Jette, AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 1993;46:153-62. PMID 8437031.
11. Mittman N, Kuramoto L, Seung SJ, et al. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med 2008;102:413- 21. Epub 2007 Dec 20. PMID: 18086519.